To date, GAD antibodies have been found in increased titer in Miller Fisher syndrome, a condition with a presynaptic neuromuscular transmission defect [14], and myasthenia gravis [15], where the defect occurs at the postsynaptic region. Here, GAD1 is linked to Miller Fisher syndrome.